Literature DB >> 16260600

Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4.

Jun Wang1, Pierre Paradis, Anne Aries, Hiba Komati, Chantal Lefebvre, Hao Wang, Mona Nemer.   

Abstract

Angiotensin II (AII), a potent vasoactive hormone, acts on numerous organs via G-protein-coupled receptors and elicits cell-specific responses. At the level of the heart, AII stimulation alters gene transcription and leads to cardiomyocyte hypertrophy. Numerous intracellular signaling pathways are activated in this process; however, which of these directly link receptor activation to transcriptional regulation remains undefined. We used the atrial natriuretic factor (ANF) gene (NPPA) as a marker to elucidate the signaling cascades involved in AII transcriptional responses. We show that ANF transcription is activated directly by the AII type 1 receptor and precedes the development of myocyte hypertrophy. This response maps to STAT and GATA binding sites, and the two elements transcriptionally cooperate to mediate signaling through the JAK-STAT and protein kinase C (PKC)-GATA-4 pathways. PKC phosphorylation enhances GATA-4 DNA binding activity, and STAT-1 functionally and physically interacts with GATA-4 to synergistically activate AII and other growth factor-inducible promoters. Moreover, GATA factors are able to recruit STAT proteins to target promoters via GATA binding sites, which are sufficient to support synergy. Thus, STAT proteins can act as growth factor-inducible coactivators of tissue-specific transcription factors. Interactions between STAT and GATA proteins may provide a general paradigm for understanding cell specificity of cytokine and growth factor signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260600      PMCID: PMC1280254          DOI: 10.1128/MCB.25.22.9829-9844.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  85 in total

Review 1.  Angiotensin peptides and inducible transcription factors.

Authors:  A Blume; T Herdegen; T Unger
Journal:  J Mol Med (Berl)       Date:  1999-03       Impact factor: 4.599

Review 2.  Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling.

Authors:  Scott Barolo; James W Posakony
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

Review 3.  The GATA family (vertebrates and invertebrates).

Authors:  Roger K Patient; James D McGhee
Journal:  Curr Opin Genet Dev       Date:  2002-08       Impact factor: 5.578

Review 4.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

5.  Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart.

Authors:  Tomoaki Osugi; Yuichi Oshima; Yasushi Fujio; Masanobu Funamoto; Atsuko Yamashita; Shinji Negoro; Keita Kunisada; Masahiro Izumi; Yoshikazu Nakaoka; Hisao Hirota; Masaru Okabe; Keiko Yamauchi-Takihara; Ichiro Kawase; Tadamitsu Kishimoto
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

6.  Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway.

Authors:  Dinesh Kalra; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

7.  Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes.

Authors:  Etsu Suzuki; Hiroaki Nishimatsu; Hiroshi Satonaka; Kenneth Walsh; Atsuo Goto; Masao Omata; Toshiro Fujita; Ryozo Nagai; Yasunobu Hirata
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

8.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  A functional role of Stat3 in in vivo megakaryopoiesis.

Authors:  Keita Kirito; Masatake Osawa; Haruhiko Morita; Ritsuko Shimizu; Masayuki Yamamoto; Atsushi Oda; Hiroyoshi Fujita; Masaru Tanaka; Koichi Nakajima; Yasusada Miura; Keiya Ozawa; Norio Komatsu
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

10.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more
  32 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Authors:  Julio Cesar Batista Ferreira; Patricia Chakur Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

3.  Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.

Authors:  Hongxia Li; Shi Zuo; Zhisong He; Yueting Yang; Zeeshan Pasha; Yigang Wang; Meifeng Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-24       Impact factor: 4.733

Review 4.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

5.  EGF is required for cardiac differentiation of P19CL6 cells through interaction with GATA-4 in a time- and dose-dependent manner.

Authors:  Cai-Xia Ma; Yang-Liu Song; Liyun Xiao; Li-Xiang Xue; Wen-Juan Li; Brigitte Laforest; Hiba Komati; Wei-Ping Wang; Zhu-Qing Jia; Chun-Yan Zhou; Yunzeng Zou; Mona Nemer; Shan-Feng Zhang; Xiaowen Bai; Huijian Wu; Ming-Xi Zang
Journal:  Cell Mol Life Sci       Date:  2014-12-14       Impact factor: 9.261

6.  Dissociation of cardiogenic and postnatal myocardial activities of GATA4.

Authors:  Joseph M Gallagher; Hiba Komati; Emmanuel Roy; Mona Nemer; Branko V Latinkić
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 7.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

8.  GATA augments GNRH-mediated increases in Adcyap1 gene expression in pituitary gonadotrope cells.

Authors:  Robin L Thomas; Natalie M Crawford; Constance M Grafer; Weiming Zheng; Lisa M Halvorson
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

9.  ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling.

Authors:  Hiba Komati; Wael Maharsy; Janie Beauregard; Salim Hayek; Mona Nemer
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

10.  Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

Authors:  Yoichi Sunagawa; Tatsuya Morimoto; Tomohide Takaya; Shinji Kaichi; Hiromichi Wada; Teruhisa Kawamura; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.